DOI:
10.1055/s-00000002
Aktuelle Dermatologie
LinksClose Window
References
Dummer R, Schadendorf D, Ascierto PA. et al.
Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol 2017;
18: 435-445
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.